DNAJC5 and malaria: The efficacy of the Prime+μCaps-M regimen was tested in a mouse model of lethal malaria challenge by intravenous injection of transgenic Plasmodium berghei (Pb) sporozoites carrying the P. falciparum circumsporozoite (CSP) gene.